NODAL and prostate carcinoma: To determine whether Nodal treatment affected prostate cancer cell angiogenesis, DU145 cells and LNCaP cells were divided into three groups: control, Nodal, and Nodal+SB431524, where SB431524 is an inhibitor of Nodal.